Is American Express Stock Still Worth Buying After Earnings?

American Express posted strong Q1 results with billed business up 10% to $428 billion, revenue up 11% to $18.9 billion, and net income up 15% to $2.97 billion, while maintaining full-year guidance for 9% to 10% revenue growth and EPS of $17.30 to $17.90. The article argues the stock's tepid reaction reflects concerns over inflation, war-related macro pressure, and potential AI disruption, but says Amex's affluent customer base and rewards franchise should support continued double-digit growth.

Analysis

AXP is acting like a quality-duration trade rather than a simple consumer cyclical: the market is discounting the durability of its growth, but the underlying mix still supports premium compounding. The key second-order read is that affluent spenders are typically the last cohort to pull back in a slowdown, so even if aggregate consumer data softens, Amex can keep taking share in travel, entertainment, and high-ticket categories where rewards economics matter most.

The bigger mispricing is around operating leverage. Management is leaning into marketing and technology while still guiding to double-digit EPS growth, which implies incremental spend is being absorbed by a business with structural pricing power and low credit stress. If that mix holds for 2-3 more quarters, consensus likely has to move from treating this as a “steady compounder” to a higher-quality earnings revision story, especially if billed business growth stays near the low-double-digit range.

AI disruption is a real long-dated threat, but the market may be overestimating its near-term impact on fee pools. The path of least resistance for AI agents is optimization within the existing card ecosystem, not mass abandonment of it; disintermediation only works if consumers give up rewards, float, fraud protection, and acceptance convenience. That makes the more relevant risk over the next 12-24 months a competitive response from network peers and fintechs, not a sudden collapse in AXP’s economics.

Near term, the stock looks vulnerable only if macro fear compresses discretionary spend or if guidance gets proven too conservative. Absent that, this is a classic “good quarter, no narrative change” setup where the move may be underdone and a rerating could happen on one more clean print rather than on headlines alone.

Key Decisions for Investors

• Buy AXP on weakness over the next 1-3 weeks; prefer entry on any broad-market risk-off tape. Risk/reward is favorable for a 6-12 month hold if billed business continues growing ~high single to low double digits and EPS revisions follow.
• Pair trade: long AXP / short KRE for 3-6 months. The thesis is that high-quality consumer credit and affluent spending are more resilient than regional-bank margin sensitivity and credit normalization.
• Sell near-dated downside protection only if already long AXP: consider a 1-2 month cash-secured put or put spread around 5-8% below spot to monetize the market’s complacency while keeping downside defined.
• Avoid shorting AXP on AI disruption alone. The disintermediation thesis is too early; if you want to express that view, wait for evidence of lower card spend or weaker reward redemption behavior rather than paying for optionality now.
• Watch for a second consecutive quarter of double-digit billed business and stable credit metrics; that would be the catalyst to add size, as it would likely force multiple expansion more than earnings alone.